Ms. Schwartz, who has a real-time net worth of $1.7 billion, started Bio-Rad Laboratories with her husband in 1952.
She and her husband launched the company in California with $720 in savings. Bio-Rad now sells 10,000 life science research and clinical diagnostics products, and its 2022 revenue was $2.8 billion.
Ms. Schwartz stepped down from the company’s board in 2012, appointing her son as its chairman and CEO.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.